Shareholder Q&A

Shareholders should read the information set out in the circular to shareholders dated 28 May 2025 (the Circular). The Circular sets out the information about the proposed tender offer in detail. Shareholders should only base their decision on voting and whether or not to participate in the proposed tender offer on the information set out in the Circular and should not rely solely on this webpage.

1. What is happening?

CQS Natural Resources Growth and Income PLC (the Company) has announced a path forward to enhance value for all shareholders following a comprehensive strategic review.

The Board is proposing a free choice between remaining invested in the Company with value enhancing initiatives (including a reduced investment management fee and an enhanced dividend) and/or exiting for cash (partially or fully) through a tender offer. You can read the Circular here.

2. What was the outcome of the Strategic Review?
Value enhancing initiatives

The Company shall implement the following changes:

  • reduction of investment management fee with effect from 1 May 2025 to a flat 1 per cent. per annum of the net asset value of the Company (a 0.2 percentage point reduction on the current highest tier of fee);
  • subject to the passing of the resolutions:
    • adoption of an enhanced annual dividend of circa 8 per cent via a quarterly dividend policy of 2 per cent. of the preceding quarter-end net asset value per share using capital reserves as necessary and without any alteration to the current investment strategy; and
    • in order to provide shareholders who remain invested with the Company after the tender offer with a period of stability, a postponement of the next continuation vote until the AGM to be held in 2028 and biennial continuation votes thereafter, in accordance with good governance standards, subject also to the completion of the Tender Offer.
Tender offer

A tender offer is an offer by a company to repurchase some or all of its listed shares. Before the proposed tender offer can proceed, a resolution must be put to shareholders at a general meeting. The resolution requires at least 75 per cent. of the votes cast at the general meeting to be in favour of proceeding with the proposed tender offer.

If approved, shareholders will have two options in relation to the proposed tender offer:

  • Keep all of their shares in the Company (no action required, but shareholders are encouraged to vote at the general meeting); or
  • Elect to sell some or all of their shares back to the Company (complete the tender form or accept the tender via CREST).

The Board is proposing a tender offer of up to 100 per cent. of the Company's issued share capital which means that shareholders have the right to sell their entire registered holding of shares as at 29 May 2025, back to the Company. The general meeting will be held on 25 June 2025.

What are the benefits for keeping my shares in the company?
  • Adoption of an enhanced quarterly dividend policy of 2 per cent. of the preceding quarter-end NAV per Share (circa. 8 per cent. annual dividend), on the passing of the resolutions
  • Reduced management fee to a flat 1 per cent. per annum of NAV from 1 May
  • A period of stability by pushing out the continuation vote to 2028; followed by a biennial continuation vote, upon completion of the Tender Offer.
  • The Board firmly believes in the attractions of the Company and the opportunities that it offers investors: the Company will remain a specialist investment trust, providing diversified access to under-researched mid and smaller-cap companies across the natural resources sector, globally, and with a strong record of outperformance over the medium and long term.
  • Standstill agreement with Saba that they will not requisition a general meeting or seek to remove the directors
3. Who can participate in the proposed tender offer?

UK and U.S. resident shareholders will be able to participate in the proposed tender offer, in respect of shares they held on 29 May 2025.

Shareholders resident in other overseas jurisdictions will need to inform themselves about the applicable local requirements in respect of the proposed tender offer and observe these. In some jurisdictions, taking up the proposed tender offer may be prohibited so shareholders should seek appropriate professional advice.

The proposed tender offer is not available to shareholders in Australia, Canada, the EEA, Japan, New Zealand or South Africa.

Please note that once shares have been elected for the tender offer, this cannot be withdrawn, and you will be unable to sell those shares during this time.

4. I purchased my shares on 28 May 2025, can I participate in the proposed tender offer?

The record date is set as 6.00 p.m. on 29 May 2025. To be on the register at this time, you typically would have had to purchase your shares on or prior to 27 May 2025 under normal settlement (being t+2 trading days).

Only shareholders who owned settled shares on or before the record date will be eligible to participate in the tender offer.

If you're unsure, please consult your broker or financial advisor to understand your rights based on the timing of your purchase.

5. At what price will I be able to sell my shares, and will it be at NAV?

We cannot say at this point what price shareholders will receive for their shares. The Company's assets will be divided between those shareholders wishing to continue investing in the Company and those wishing to sell some or all of their shares back to the Company.

To pay shareholders for the shares they wish to sell to the Company, the assets apportioned to those shareholders (referred to as the tender pool) will need to be sold. The price shareholders receive for their tendered shares can only be calculated when all of the apportioned assets have been sold, which is expected to be completed around 30 September 2025. Market conditions may change in that time and shareholders should be aware that they may get back less than the prevailing share price at the date that payment is sent to them.

The costs of the proposed tender offer and the cost of realising the assets apportioned to the tender pool will be reflected in the tender price.

6. When will I receive the cash from the proposed tender offer?

The proposed tender offer closes on 30 June 2025 and the assets will start to be sold from the beginning of July. All portfolio holdings are currently expected to be sold by 30 September 2025, with payments to shareholders via CREST and cheque during the week thereafter. However, the time to sell the assets will depend on the market environment, and the Company will make an announcement to the market once the payment date and price per tendered share are confirmed.

7. Will the directors be selling shares in the proposed tender offer?

No. None of the directors that own shares in the Company intend to participate in the proposed tender offer.

8. Do I have to sell all my shares in the proposed tender offer?

No. If you do not wish to sell all or a portion of your shares, please take no further action.

You will remain a shareholder in the Company and benefit from the enhanced value initiatives proposed by the Board.

9. What happens if all shareholders tender their shares?

If more than 60 per cent. of the shares in the Company are tendered, the tender offer will be cancelled, and the Directors would bring forward proposals for winding up of the Company instead.

10. How do I participate in the proposed tender offer?

Shareholders wishing to participate in the proposed tender offer and holding their shares in certificated form should complete the tender form and return this, along with their share certificate, to Equiniti Limited, Corporate Actions, Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA by no later than 1.00 p.m. on 30 June 2025.

Shareholders holding their shares through a nominee or share dealing platform, such as Hargreaves Lansdown, Halifax Share Dealing, AJ Bell and similar, should receive a notification from their platform regarding the proposed tender offer. The closing date to participate in the proposed tender offer is 30 June 2025, however, each of the platforms will have an earlier deadline, details of which should be contained in the notification shareholders receive from their respective platforms. If these shareholders have any questions regarding participating in the proposed tender offer, they should contact their platform.

11. What costs will shareholders need to bear?

The costs of the proposed tender offer will be borne by shareholders electing to sell their shares back to the Company. These shareholders will also bear the costs of realising the assets apportioned to them. These costs will be deducted from payment before it is sent to shareholders. No costs will be borne by continuing shareholders.

12. Will the Company still have a continuation vote?

If shareholders agree by voting in favour of Resolution 2, the Company will hold continuation votes every two years starting at the 2028 AGM.

13. When will the management fee be reduced?

The investment management fee reduction took effect on 1 May 2025.

14. When will the first enhanced dividend be paid?

Subject to the passing of the resolutions, the first of these dividends will be paid based on the NAV as at 30 June 2025 with the payment expected to be made in September. Both tendering and continuing shareholders will receive the dividend.

15. Do I need to vote?

Both the proposed tender offer and change to the frequency of the continuation vote are subject to shareholder approval. The Board recommends all shareholders to vote on the proposals regardless of whether they intend to tender their shares. The deadline to submit a proxy vote ahead of the general meeting is by midday on 23 June 2025, however, shareholders holding their shares through a nominee or share dealing platform will have an earlier deadline. You will find more information on how to vote here.

16. What are the important dates in this transaction?

The expected timetable is as follows. If any dates change there will be an announcement made to the stock exchange.

EXPECTED TIMETABLE – 2025
Publication of this document and Tender Offer opens28 May
Record Date for the Tender Offer6 p.m. on 29 May
Latest time and date for receipt of Form of Proxy for the General MeetingMidday on 23 June
General MeetingMidday on 25 June
Latest time and date for receipt of Tender Forms and submission of TTE Instructions from Eligible Shareholders1 p.m. on 30 June
Calculation DateClose of business on 30 June
Results of Tender Offer announced and confirmation that the Tender Offer will proceed7.00 a.m. on 1 July
Establishment of Tender Pool and Continuing Pool and realisation of Tender Pool commences1 July
Tender Price announced and payment date announcedAs soon as practicable but expected to be by 30 September
Repurchase of the Tender Exit Shares announcedAs soon as practicable but expected to be by 2 October
CREST Settlement Date: payments through CREST made and CREST accounts settled for tendered Shares7 October (within 5 Business Days from announcement of Tender Price)
Cheques for certificated Shareholders despatched14 October (within 10 Business Days from announcement of Tender Price)
17. Who should I contact if I have queries?

Shareholders should contact the Company's registrar, Equiniti on 0371 384 2050 or by post at Equiniti Limited, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA.

If you hold your shares through a platform, please contact your platform provider.

Archive: Requisitioned General Meeting – 4 February 2025
1. What is the Board of Directors recommending I do?
  • The Board of Directors find the proposals are fundamentally without merit and remains fully committed to act in the best interests of all Shareholders.
  • Your Board unanimously recommends that Shareholders VOTE AGAINST all of the Requisitioned Resolutions as soon as possible.
2. Why should I vote against all the Saba Resolutions?
Your board:
  • Has overseen strong performance, with 167% total return in NAV and 220% total return in share price since the current joint fund managers were appointed in October 2015.
  • Believes Manulife | CQS and the joint fund managers, who are widely recognised as being leading investors in their field, are the team best placed to continue this strong performance in natural resources sector you have chosen to invest in.
  • Is fully independent and has deep experience in investment trusts, natural resources, the UK investment management sector, finance and accounting, and as directors of quoted companies.
  • In line with the highest standards of corporate governance, maintains an annual continuation vote, which facilitates 100% cash return should that be the wish of the majority of Shareholders voting.
  • Is committed to creating and preserving value for ALL Shareholders.
Saba Capital:
  • Have failed to state how much cash they will return to you.
  • Are expected to appoint themselves as manager, as set out in their statement to Shareholders, we believe for their own economic gain.
  • Are expected to propose to change your Company's investment policy from the strategy that you selected, to an approach of investing in other trusts for which no track record has been provided.
  • Have failed to narrow the discounts of the funds that they have taken control of in the US, compared with their long-term averages, and your investment may become trapped at a long-term discount.
  • Have proposed directors who we do not believe to be independent of Saba, with no experience in natural resources and who, despite Saba's misleading claims, appear to have no experience of directing investment trusts.
3. Why has Saba requested a general meeting for shareholders?
  • Saba (which has built a holding of 29.07%) has requested that CYN convene a general meeting and have invited Shareholders to consider resolutions to remove the current Board of Directors of the Company, and appoint Paul Kazarian of Saba and Marc Loughlin as new directors in their stead.
  • The CYN Board considers these proposals to be fundamentally without merit and remains fully committed to act in the best interests of ALL Shareholders.
  • All Shareholders are encouraged to VOTE AGAINST the Requisitioned Resolutions to be proposed at the Requisitioned General Meeting and, if the Shareholders do not hold their shares directly, to arrange for their nominee to vote against the Requisitioned Resolutions on their behalf.
4. What will happen to my investment if Saba is successful?
  • If Saba is successful in this undertaking, it will remove the current Board of Directors and appoint two directors with no apparent experience in the natural resources sector in their stead. It is expected that they will propose Saba as the investment manager in order to introduce a new investment strategy (as outlined in their statement to Shareholders).
  • This strategy has not been outlined in detail, but it is expected that Saba intend to change the Company's investment policy away from natural resources to investing in other investment trusts, likely investing outside the sector you chose.
  • Saba's potential proposals means that after an initial provision of liquidity, the majority of your investment could be locked in what might become a highly illiquid fund.
  • It is highly uncertain that Saba's interests are aligned with long term Shareholders, and introduces a new level of risk for retail investors.
5. What will happen to my investment if the resolutions are overturned?
  • Your Board has always been, and continues to be, committed to the interests of all Shareholders. A key area of attention is delivering Shareholder value and ensuring the strongest corporate governance and transparency.
  • Regular and transparent communication, share buybacks, and a continuation vote provide Shareholders with the tools they need to make an informed investment decision and a voice for the future of their fund.
  • The Board is currently reviewing the following:
    • Maintaining the current investment policy and management arrangements, given the best practice annual continuation vote, together with providing liquidity to Shareholders by means of buybacks, tenders and other similar actions;
    • Introducing an increased dividend, to be funded in part by capital growth;
    • Pursuing further discount management mechanisms;
    • Providing a full cash exit at NAV for all Shareholders; and
    • If a suitable partner can be identified, to negotiate terms of a combination with another investment trust or open-ended investment company that would provide an ongoing investment opportunity with a natural resources and energy focus, together with the option of a full cash exit at NAV for all Shareholders.
  • Your Board expects to announce the outcome of its current review during the course of the Company's current financial year i.e. by 30 June 2025 at the latest.
  • Importantly, your Board believes that implementing any one, or any combination, of these options will represent a much better outcome for Shareholders as a whole, rather than accepting Saba's proposals.
6. Has Saba done this before and were they successful?
  • Saba are manager of two closed-end funds quoted on the NYSE following a similar campaign in July 2020 – Saba Capital Income & Opportunities Fund (“SIOF”), and in November 2023 – Saba Capital Income & Opportunities Fund II (“SIOF-II”).
  • It is clear that Saba's proposals in the US have not led to a long-term narrowing of the discount. The liquidity offered through the tenders and net demand for the shares afterwards were inadequate to prevent the discounts reverting to the average.
7. How do I vote?

All Shareholders are encouraged to VOTE AGAINST the Requisitioned Resolutions to be proposed at the Requisitioned General Meeting. Investors who hold their Shares through an investment platform provider or nominee are encouraged to contact their investment platform provider or nominee as soon as possible to arrange for VOTE AGAINST each of the Requisitioned Resolutions to be lodged on their behalf. The Association of Investment Companies' guidance on how to vote through investment platforms can be found on its website (https://www.theaic.co.uk/how-to-vote-your-shares).

Shareholders are requested to complete and return proxy appointments to the Registrar by one of the following means:

  1. by completing and signing the Form of Proxy for use in relation to the Requisitioned General Meeting in accordance with the instructions printed thereon and returning it by post, courier or (during normal business hours only) by hand to the Registrar at Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA;
  2. by appointing a proxy electronically via the Registrar's online proxy voting service at www.shareview.co.uk (you will need to create an online portfolio using your Shareholder Reference Number on your Form of Proxy);
  3. in the case of certain institutional shareholders, by using the Proxymity platform at proxymity.io; or
  4. in the case of CREST members, by using the CREST electronic voting service by CREST Proxy Instruction to the Registrar (CREST Participant IDRA19) in accordance with the procedures set out in the notes to the Notice of the Requisitioned General Meeting.

In each case, to be valid the proxy appointments must be completed in accordance with the instructions accompanying it and transmitted so received by the Registrar as soon as possible and, in any event, by no later than 11 a.m. on 31 January 2025.

If you are in any doubt as to the action you should take, you are recommended to seek your own financial and/or legal advice immediately from your stockbroker, bank manager, solicitor, accountant or other independent financial adviser authorised under FSMA if you are resident in the United Kingdom or, if not, from another appropriately authorised independent financial adviser.

8. What happens if I don't vote?
  • If Shareholders do not vote, the resolutions will likely be passed by Saba's 29.07% minority shareholding. In accordance with these resolutions, the Board of Directors will be replaced by two Saba candidates, Paul Kazarian and Marc Loughlin, who have no apparent experience of directing investment trusts and may not be deemed to be independent if they appoint Saba as investment managers.
  • It is unclear what strategy they will employ once these changes are effected and introduces a new level of risk to Shareholders.
  • The Board of Directors urge you to VOTE AGAINST these proposals.
9. What percentage of votes are required in order for Saba's Requisitioned Resolutions to pass?
  • The Requisitioned Resolutions will be proposed as ordinary resolutions. Accordingly, in order to be passed, each Requisitioned Resolution will require more than 50% of the votes cast in person or by proxy to be voted in favour of it.
  • If Shareholders don't vote against the Saba proposals, its 29.07% position is likely to bulldoze the vote in their favour.
  • Shareholders are strongly encouraged to VOTE AGAINST to ensure that Saba's resolutions are not carried as a result of Shareholder inaction.
10. When is the meeting and what happens next?
  • The meeting will be held at 11 a.m. on 4 February 2025, at the offices of Dentons UK and Middle East LLP at 1 Fleet Place, London EC4M 7RA, in accordance with the Companies Act 2006 s304.
  • Your proxy must be lodged by no later than 11 a.m. on 31 January 2025 in order to be considered valid.
  • All Shareholders are encouraged to VOTE AGAINST the Requisitioned Resolutions to be proposed at the General Meeting and, if the Shareholders do not hold their shares directly, to arrange for their nominee to vote against the Requisitioned Resolutions on their behalf.

Timetable:

Publication of company circular7th January
Latest time and date for receipt of Forms of Proxy, or submitting proxy instructions online at www.shareview.co.uk or through CREST in respect of the Requisitioned General Meeting11a.m. on 31 January
Record time and date for entitlement to vote at the Requisitioned General Meeting6.30 p.m. on 31 January
Requisitioned General Meeting11 a.m. on 4 February
11. Who do I contact if I have questions?
  • Please contact:
    Craig Cleland, Head of Product Development, Investment Trusts,
    Manulife | CQS Investment Management
    craig.cleland@cqsm.com
  • You will also be able to ask questions in person at the meeting.
12. Where can I find more information about CYN?